Post Profile

FDA Issues Draft Guidance For Early Version Of An Artificial Pancreas System

The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States. Type 1 diabetes is a chronic condition in which the pancreas produces little or no insulin, a hormone needed to properly control blood glucose (sugar) levels. Without enough insulin, glucose builds up in the bloodstream instead of going into the cells.
read more


Related Posts

FDA Issues Two Draft Guidance Documents To Facilitate Investigational Medical Device Studies In Humans

Health : Medical News Today

The U.S. Food and Drug Administration today issued a draft guidance aimed at fostering early-stage development of medical devices within the United States. Doing early-stage development is important to help stimulate U.S.-based inno...

Artificial Pancreas Approved for US Outpatient Testing

Health : Newswise Medical News

A University of Virginia-developed artificial pancreas that could potentially automate care for millions of Type 1 diabetes patients has received U.S. Food and Drug Administration (FDA) approval for a key testing phase. The FDA rece...

Artificial Pancreas - FDA Provides Options For Designs And Studies

Health : Medical News Today

A draft guidance to help artificial pancreas researchers and makers as they create and submit their devices for FDA approval has been issued by the Agency. Artificial pancreases are currently being designed and created for the treat...

Advocates, 150 Children With Type 1 Diabetes Urge FDA To Enable Critical Research On Life-Saving Artificial Pancreas To Move Forward

Health : Medical News Today

Kevin Kline and four children with type 1 diabetes urged the Food and Drug Administration (FDA) to take immediate action to accelerate the research and review of artificial pancreas systems at a hearing before the Senate Committee o...

FDA issues guidance for artificial pancreas

Health : The Chart

The FDA issued draft guidance on Thursday, intended for researchers and device manufactures working to develop and gain FDA approval for an artificial pancreas device system for treating type one diabetes. In June 2011, the FDA prov...


Copyright © 2016 Regator, LLC